Your new position 

The US Director, HEOR & RWE will lead the design, execution, and communication of health, economic and outcomes research strategies supporting the company’s global metabolic health portfolio. This leader will generate high-quality real-world, clinical, and economic evidence to demonstrate product value to payers, providers, patients, and policymakers. The role requires expertise in value demonstration, real-world data (RWD), and outcomes modeling, as well as the ability to translate complex data into actionable insights for commercial and clinical decision-making. Remote location, ideally NE cooridor

Responsibilities:

• HEOR & Evidence Generation Strategy
• Develop and implement integrated global HEOR strategies to support pipeline and lifecycle management programs with a US launch focus
• Real-World Data & Value Communication
• Lead development of US RWD strategies and partnerships with academic consortia, claims databases, and health systems to support value demonstration tive effectiveness and longitudinal outcomes studies
• Design and implement real-world data analyses to understand and articulate the current patient demographics, treatment patterns, and outcomes
• Develop AMCP value dossiers, economic modelling and narratives and scientific publications to support value propositions
• Serve as a key domain expert for payer engagement, providing evidence summaries and presentations that strengthen product positioning and formulary access
• Engage and collaborate with external partners including payers, providers, and other access decision-makers to establish / maintain strong partnerships and gather insights
• Lead the external dissemination of HEOR/RWE deliverables including publications, presentations, and professional conferences
• Provide input to clinical development programs
• Partnerships & Cross-Functional Collaboration
• Collaborate closely with partners on HEOR & RWE programs, ensuring coordinated evidence generation, cost-sharing, and data-sharing aligned to global commercialization goals.
• Represent HEOR in relevant governance meetings, advisory boards, and internal strategy sessions to shape business decisions through evidence-driven insight.

Your Profile:

• PhD, PharmD, MPH, or Master’s in Health Economics, Outcomes Research, Epidemiology, or a related discipline.
• 8–12 years of HEOR/RWE experience in biotech, pharmaceutical organizations or consultancies with demonstrated success in pre-launch and commercialization phases.
• Therapeutic area expertise in metabolic, endocrine, or cardiometabolic diseases strongly preferred.
• Deep understanding of payer and evidence requirements in the U.S.
• Proficiency in RWD study design and analysis, and patient outcome measure development.
• Proven ability to communicate complex data to non-technical audiences, including payers, regulators, and cross-functional business leaders.
• Experience leading external collaborators, vendors, and cross-company joint HEOR initiatives.
• Publication track record and presentation experience at peer-reviewed scientific meetings.
   

Let’s bond and be bold ​ 
We have a unique culture, characterized by excellent teamwork and strong engagement across the organization.​ And we want you to help us strengthen this culture. 

Making bonds is at the core of everything we do. From discovering and developing the best new peptide drugs for patients, to engaging with our partners or connecting with each other.​ We bond through curiosity and playfulness as a team, allowing ourselves to challenge common thinking and drive future innovation. Join us and let’s bond and be bold ​ 

Interested in bonding with us? Then please apply no later than March 2nd, 2026, or as soon as possible. The applications will be reviewed as they come in. While a cover letter is not required, please include a few sentences in your CV explaining your motivation for applying.

We are committed to an inclusive recruitment process and welcome applications from all job applicants. 

The anticipated base pay range for this position is :  $ 210,000 - $ 250,000

About Zealand Pharma A/S  

Zealand Pharma A/S (Nasdaq: ZEAL) is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10 drug candidates invented by Zealand Pharma have advanced into clinical development, of which two have reached the market and three candidates are in late-stage development. The company has development partnerships with a number of pharma companies as well as commercial partnerships for its marketed products. Zealand Pharma was founded in 1998 and is headquartered in Copenhagen, Denmark, with a team in the U.S. For more information about Zealand Pharma’s business and activities, please visit www.zealandpharma.com. 

#LI-Remote